AURKB as a key driver of esophageal cancer progression: Molecular mechanisms and potential nursing implications based

Xiaoling Qu1, Lihua Lu2, Xuan Dong3

  • 1Gastrointestinal Rehabilitation Center, Beijing Rehabilitation Hospital Affiliated to Capital Medical University, Shijingshan District, Beijing, China.

Medicine
|March 13, 2026
PubMed

Insights

Aurora kinase B (AURKB) is a key driver in esophageal cancer, promoting tumor growth via cell cycle regulation and ferroptosis resistance. This finding offers new targets for precision therapies and nursing interventions.

Area of Science:

  • Oncology
  • Molecular Biology
  • Bioinformatics

Background:

  • Esophageal cancer is a heterogeneous malignancy with poor prognosis and unclear molecular drivers.
  • The role of Aurora kinase B (AURKB) in esophageal cancer progression, including its expression and functional mechanisms, remains largely unelucidated.
  • Understanding these mechanisms is crucial for developing effective targeted therapies and improving patient care.

Purpose of the Study:

  • To identify key molecular drivers and pathways involved in esophageal cancer progression using integrated bioinformatics analysis.
  • To investigate the expression characteristics and functional role of AURKB in esophageal cancer.
  • To explore potential molecular targets for precision medicine and inform nursing interventions.

Main Methods:

  • Utilized public datasets (GSE164158, GSE17351) to screen differentially expressed genes (DEGs) between esophageal cancer and normal tissues.
  • Performed functional enrichment analysis (GO, KEGG, GSEA, Metascape) and constructed protein-protein interaction (PPI) networks.
  • Integrated weighted gene co-expression network analysis (WGCNA) with DEG analysis and identified core genes using multiple algorithms.
  • Analyzed immune infiltration using CIBERSORT and validated AURKB expression and associations.

Main Results:

  • Identified 1500 DEGs significantly enriched in cell cycle, DNA replication, and mitosis pathways.
  • Integrated network analyses pinpointed 4 core genes, including AURKB, which was highly expressed in esophageal cancer.
  • AURKB expression correlated with aggressive tumor features, and immune infiltration analysis revealed significant heterogeneity.
  • AURKB promotes esophageal cancer progression via cell cycle regulation and ferroptosis resistance.

Conclusions:

  • AURKB is identified as a key driver gene in esophageal cancer, influencing tumor progression through cell cycle control and ferroptosis resistance.
  • This study provides a theoretical foundation and potential molecular targets for targeted esophageal cancer therapies.
  • Findings offer insights for precision nursing interventions, including perioperative care, risk assessment, and rehabilitation.

Related Concept Videos

Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
1.1K
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
1.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K